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Glycan molecules from helminth parasites have been associated with diverse biological functions ranging
from interactions with neighbouring host cell populations to down-modulation of specific host
immunity. Glycoproteins secreted by the intestinal nematode Heligmosomoides polygyrus are of particular
interest as the excretory–secretory products (termed HES) of this parasite contain both heat-labile and
heat-stable components with immunomodulatory effects. We used MALDI-TOF-MS and LC–MS/MS to
analyse the repertoire of N- and O-linked glycans released from Heligmosomoides polygyrus excretory–
secretory products by PNGase A and F, b-elimination and hydrazinolysis revealing a broad range of
structures including novel methylhexose- and methylfucose-containing glycans. Monoclonal antibodies
to two immunodominant glycans of H. polygyrus, previously designated Glycans A and B, were found
to react by glycan array analysis to a methyl-hexose-rich fraction and to a sulphated LacDiNAc
(LDN; GalNAcb1–4GlcNAc) structure, respectively. We also analysed the glycan repertoire of a major
glycoprotein in Heligmosomoides polygyrus excretory–secretory products, VAL-2, which contains many
glycan structures present in Heligmosomoides polygyrus excretory–secretory products including Glycan A.
However, it was found that this set of glycans is not responsible for the heat-stable immunomodulatory
properties of Heligmosomoides polygyrus excretory–secretory products, as revealed by the inability of
VAL-2 to inhibit allergic lung inflammation. Taken together, these studies reveal that H. polygyrus secretes
a diverse range of antigenic glycoconjugates, and provides a framework to explore the biological and
immunomodulatory roles they may play within the mammalian host.
 2015 The Authors. Published by Elsevier Ltd. on behalf of Australian Society for Parasitology Inc. This is
an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
The prominence of glycan structures in the immune recognition
of parasitic helminths has been known for nearly 70 years
(Campbell, 1936). Indeed, anti-carbohydrate specificities have
been found to dominate the host antibody response in many differ-
ent helminth infections (Omer-Ali et al., 1986; Maizels et al., 1987;
Eberl et al., 2001; Kariuki et al., 2008; Hewitson et al., 2011;
Paschinger et al., 2012). However, the generation of anti-glycan
antibodies occurs both in susceptible hosts lacking overt anti-
parasite immunity (Omer-Ali et al., 1986; Eberl et al., 2001;Kariuki et al., 2008), as well as in immunised animals resistant
to infection (Vervelde et al., 2003; Kariuki et al., 2008). In
some instances it is possible that glycan epitopes eliciting
non-protective antibodies may even block potentially protective
anti-protein responses (Dunne et al., 1987). As helminth molecules
become better defined at the structural level, it is likely that the
contrasting roles of specific glycans will become resolved.
Indeed, as the range and complexity of helminth-associated gly-
cans become increasingly well-characterised, it is already clear
that many specific glycans and carbohydrate motifs fulfil critical
and important biological roles in the host–parasite relationship
(Maizels and Hewitson, 2012; Prasanphanich et al., 2013). Most
importantly, they can direct and modify the development of
immunity to the benefit of the parasite (van Die and Cummings,
2010; Prasanphanich et al., 2013). This occurs through glycan
binding to host pattern recognition receptors, particularly lectins
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Vliet et al., 2005; Saunders et al., 2009; Meevissen et al., 2012;
Klaver et al., 2013) and galectins (van den Berg et al., 2004;
Breuilh et al., 2007; Burton et al., 2010), which are expressed by
host innate cells such as dendritic cells (DC) and macrophages.
CLR-triggered signalling pathways can both cooperate with and
antagonise Toll-like receptor (TLR) signalling in helminth infection
(van Liempt et al., 2007; Ritter et al., 2010; van Stijn et al., 2010a;
Terrazas et al., 2013). Carbohydrate-specific interactions can fur-
ther promote Th2 differentiation, as shown in the example of the
schistosome x-1 glycoprotein which enters cells through glycan
binding to the mannose receptor, and subsequently subverting
DC gene expression (Everts et al., 2012).
A well-studied helminth model system is that of the mouse
intestinal nematode Heligmosomoides polygyrus, which reproduces
the chronic infection pattern of both human and veterinary
parasites (Reynolds et al., 2012). Infected mice mount dominant
antibody responses to two distinct glycosylated antigens, termed
Glycan A and Glycan B (Hewitson et al., 2011). Glycan A is an
O-linked sugar present in the secretory products of adult parasites,
termed H. polygyrus excretory–secretory products (HES), that are
highly immunomodulatory (Grainger et al., 2010; McSorley et al.,
2012, 2014). Glycan A is conjugated to abundantly secreted pro-
teins including venom allergen/Ancylostoma secreted protein-like
(VAL)-1 and -2, which are members of a large multi-gene
CAP-domain family (Pfam00188) expressed in many phyla
including nematodes, cestodes and chordates (Gibbs et al., 2008;
Cantacessi et al., 2009; Chalmers and Hoffmann, 2012). The Glycan
A epitope is also expressed on the surface of both tissue-stage
larvae and adult parasites (Hewitson et al., 2011, 2013). In contrast,
Glycan B is present on a heterogeneous high molecular weight
component that is highly abundant in parasite somatic tissues, as
well as some glycoproteins such as those released from eggs in
the intestinal lumen (Hewitson et al., 2011, 2013).
To assess the potential immunological properties of parasite gly-
cans, both as targets of the host antibody response and as potential
immunomodulators, we characterised the glycan structures within
HES and investigated the structures of Glycan A and Glycan B
through multiple approaches including antibody binding to glycan
arrays, chemical deglycosylation and MS-based structural analysis.
In addition, we analysed the glycosylation of a major glycoprotein
component of HES, VAL-2 that bears Glycan A. These data reveal
the range of novel structures from this helminth, including methy-
lated fucose and hexose components that form antibody targets.
Additionally, experiments with purified native VAL-2 reveal that,
unlike total HES, this major glycoprotein (and by implication Gly-
can A) is unable to down-regulate allergic lung inflammation.2. Materials and methods
2.1. Parasite material and antibodies
Adult HES material was collected as described elsewhere
(Johnston et al., 2015). Production, purification and antigen
specificity of anti-Hp monoclonal antibodies and generation of
secondary infection immune sera were as reported previously
(Hewitson et al., 2011). Native VAL-2 and VAL-3 were affinity-
purified from HES using specific monoclonal antibodies (mAbs
5-S2 and 5-S1, respectively) coupled to Sepharose beads (Hewitson
et al., 2011), before dialysis into PBS. ES material from adult
Nippostrongylus brasiliensis (NES) was prepared as previously reported
(Holland et al., 2000). Endotoxin levels as measured by the Limulus
amebocyte lysate (LAL, Pierce, USA) assay were generally very low
and in the range of 0.01–0.1 U/lg of protein. Silver staining was
carried out as previously described (Hewitson et al., 2008).2.2. ELISA
Antibody reactivity to HES and hydrogen fluoride (HF)-treated
HES was performed as described previously (Hewitson et al.,
2011). For competition ELISA, plate bound HES was first incubated
for 30 min at 37 C with 250 lg/ml of unlabelled mAb before addi-
tion of 10 lg/ml of biotin-labelled mAb for 2 h at 37 C. Antibodies
were biotinylated with a 20-fold molar excess of biotin using
EZ-link Sulfo-NHS Biotinylation kit (Thermo Fisher Scientific,
USA). Bound biotinylated antibody was detected with 1/1000
streptavidin-horseradish peroxidase (Sigma–Aldrich, USA) and
developed as described by Hewitson et al. (2011).2.3. Release and labelling of N-glycans from HES and VAL proteins
HES (150 lg), VAL-2 or VAL-3 (both 10 lg) were incubated with
trypsin-coupled Sepharose for 16 h at 37 C with shaking. Peptides
within the supernatant were then treated with PNGase F (2 U;
Roche, Germany) for 24 h at 37 C as described previously
(Borloo et al., 2013). The reaction mixture was then applied to a
C18 reverse-phase (RP) column (150 mg; Chromabond, Macherey-
Nagel, Germany), with (glycan-containing) flow-through (2 ml of
10% acetonitrile; ACN) and wash (2 ml of water) combined, par-
tially lyophilised to remove ACN, then applied to carbon columns
(150 mg; Carbograph SPE, Grace, USA). Carbon columns were
washed with 6 ml of water and the PNGase F-released glycan pool
eluted with 3 ml of 25% ACN and 3 ml of 25% ACN/0.05% trifluo-
roacetic acid (TFA), then lyophilised. Remaining peptides and gly-
copeptides on the C18 RP column were eluted with 4 ml of 30%
ACN/0.1% TFA and 4 ml of 60% ACN/0.1% TFA then lyophilised.
These were then resuspended in 0.1 M sodium acetate buffer pH
5 and treated with PNGase A (0.2 mU; Roche) for 24 h at 37 C.
Liberated PNGase A-sensitive glycans and (glyco)-peptides were
separated as above with C18 RP and carbon columns. PNGase F
and A-released glycan pools were resuspended in 50 ll of water,
which was mixed with 50 ll of water with 2-aminobenzoic acid
(anthranilic acid, AA) labelling mix (48 mg/ml 2-AA, 1 M
2-picoline-borane dissolved in 30% acetic acid/DMSO) followed
by 2 h incubation at 65 C. Labelled glycans were then cleaned
up using Biogel P-10 (BioRad, The Netherlands) in 75% ACN,
washed with 80% ACN, then eluted with water.2.4. b-Elimination and permethylation of O-glycans from HES and VAL
proteins
Following PNGase F and A treatment, remaining (glyco)-
peptides were resuspended in 200 ll of 0.1 M NaOH/1 M NaBH4
and incubated for 24 h at 40 C. Samples were neutralised on ice
with 4 M acetic acid, lyophilised, then boric acid was removed by
repeated evaporations (seven+) in 1% acetic acid in methanol.
Released glycans were purified with C18 RP and carbon columns
as for N-glycans in Section 2.3. Samples were permethylated
exactly as described (Borloo et al., 2013).2.5. HF treatment of HES
HES (100 lg) was dialysed into 50 mM ammonium acetate
pH 7.5 and lyophilised, then twice resuspended in water and
re-lyophilised, before addition of 100 ll of HF (48% v/v; Sigma)
for 48 h at 4 C as previously described (Haslam et al., 2000).
Samples were then dried under nitrogen and washed twice
with methanol, followed by b-elimination as described in
Section 2.4.
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O-Glycans were released from lyophilised HES (500 lg) using
the Ludger Liberate Hydrazinolysis Glycan Release Kit (Ludger,
United Kingdom) according to the manufacturer’s instructions
(6 h, 60 C). Sample acidification (0.1% TFA) during the release
procedure prevents glycan peeling/degradation (Kozak et al.,
2012). O-Glycans were then labelled with AA as described for
N-glycans in Section 2.3.
2.7. Glycan arrays
Hydrazinolysis-released O-glycans were separated by RP-HPLC
as described previously (van Diepen et al., 2012a) with flow rate
500 ll/min and initial conditions: buffer A 0.1% formic acid/water
(10 min) followed by 0–100% gradient buffer B (0.1% formic
acid/95% ACN; 30 min) and 10 min isocratic elution. Fractions (F)
were collected manually based on AA fluorescent signal (F1–44).
AA-labelled glycans could only be detected in F14–26 by LC–MS/
MS (data not shown). Glycan concentrations within each fraction
were estimated by comparison with a known AA-labelled standard
glycan (H5N2-AA, data not shown). Fractions were dissolved in
20 ll of 1 spotting buffer (Nexterion Spot; Schott Nexterion, Ger-
many) with 10% DMSO in 384-well V-bottom plates (Genetix, USA)
at half log dilutions 0.03–10 lM. Samples (five of each) were
printed on epoxysilane-coated glass slides (Slide E, Nexterion)
and probed with mAb (10 lg/ml) or polyclonal mouse serum
(1/100), and analysed as before (van Diepen et al., 2012a), with sec-
ondary antibodies Alexa-Fluor 555-labelled goat anti-mouse IgM
and Alexa-Fluor 647-labelled goat anti-mouse IgG (both 1/1000;
Life Technologies, USA). Anti-HES mAbs were also tested against
a mammalian glycan array (v5.1) by Core H of the Consortium
for Functional Glycomics (details available at http://www.func-
tionalglycomics.org/static/consortium/resources/resourcecoreh17.
shtml). Arrays were probed as described elsewhere (van Stijn et al.,
2010b).
2.8. MALDI-TOF(/TOF) MS and LC–MS analysis
Glycans were analysed as described (Smit et al., 2015) with an
Ultraflex II MALDI-TOF mass spectrometer (Bruker Daltonics,
Germany) in negative ion (AA labelled PNGase F and A-released
N-glycans) or positive ion (permethylated b-elimination-released
O-glycans) reflectron mode with 2,5-dihydroxy benzoic acid
(DHB) (20 mg/ml in 20% ACN) as matrix. N-glycans were eluted
directly onto target plates with matrix following Zip-Tip C18. MS
spectra were annotated using Glyco-Peakfinder (http://www.
glyco-peakfinder.org/). For LC–MS analysis, glycans were applied
to a RP column (PepMap, 3 lm  75 lm  100 mm) using an Ulti-
mate 3000 nano-LC system (both Dionex/LC Packings) at room
temperature. The column was equilibrated with eluent A (0.1% for-
mic acid/water) at flow rate 200 nl/min. Following sample injec-
tion, conditions were changed to 10% solvent B (0.1% formic
acid/95% ACN) with a gradient to 60% B over 45 min, then isocratic
elution for 10 min. The LC column was coupled to an Esquire HCT
Ultra ESI-IT-MS (Bruker Daltonics) equipped with an online
nanospray source in positive-ion mode. Conditions were as in
Borloo et al. (2013). Ions from m/z 300–1800 and 140–2200 were
registered in MS and MS/MS mode, respectively. MS/MS spectra
were manually interpreted using Bruker Daltonics DataAnalysis
software (Bruker Daltonics).
2.9. OVA airway allergy model and mice
Induction of airway inflammation was carried out in BALB/c
female mice as previously described (McSorley et al., 2012, 2015)with HES (5 lg) or VAL-2 (2 lg) added as soluble proteins to a sus-
pension of alum-precipitated ovalbumin (OVA), and injected i.p. in
PBS on days 0 and 14. Heat inactivation of proteins was carried out
at 100 C for 20 min. At 28, 29 and 30 days, mice were challenged
with ovalbumin in the airways and at day 31 lung tissue and bron-
chioalveolar lavage (BAL) cells were analysed by flow cytometry
for CD45.2+CD11b+SiglecF+SShi eosinophil infiltration as a marker
of allergic inflammation (McSorley et al., 2012). All animal proto-
cols adhered to the guidelines of the UK Home Office, complied
with the Animals (Scientific Procedures) Act 1986, were approved
by the University of Edinburgh Ethical Review Committee, and
were performed under the authority of the UK Home Office Project
Licence number 60/410.3. Results
3.1. Glycan array analysis indicates that Glycan A is a novel structure,
whilst Glycan B is related to sulphated glycosaminoglycan molecules
Infection with H. polygyrus elicits an immunodominant anti-
body response against two glycan targets defined as Glycans A
and B (Hewitson et al., 2011). Glycan A is an O-linked sugar cou-
pled to multiple carrier proteins, most prominently members of
the CAP superfamily of glycoproteins (Pfam00188) which includes
several VAL antigens. Glycan B is present on high molecular weight
species which migrate diffusely on SDS–PAGE as well as a 65-kDa
molecule distinct from the VAL proteins (Hewitson et al., 2011).
Panels of mAbs directed against Glycans A and B were used to
screen an extensive glycan array (Consortium for Functional Gly-
comics (CFG), v5.1) containing 610 native and synthetic sugars,
predominantly related to mammalian glycosylation. Similar
screening has previously been performed with polyclonal antisera
against the related parasites Haemonchus contortus (van Stijn et al.,
2010b) and Trichinella spiralis (Aranzamendi et al., 2011), as well as
mAbs to tumour-associated epitopes (Noble et al., 2013; Chua
et al., 2015). First, three IgM anti-Glycan A mAbs (mAbs 13.1, 3–
42 and 3–55) were selected as showing the highest binding affinity
to HES by ELISA from amongst 12 available antibodies (Supple-
mentary Fig. S1). These mAbs, however, did not bind to any of
the glycans on the array (data not shown). Anti-Glycan A mAbs
also failed to react with ES material obtained from the closely-
related rat nematode, N. brasiliensis (data not shown), suggesting
that Glycan A is a novel structure specific to H. polygyrus.
In contrast to anti-Glycan A mAbs, all three anti-Glycan B mAbs
tested (mAbs 9.1.3, 5-S19 and 4-M7 (Hewitson et al., 2011)) showed
significant binding to several related structures (Fig. 1). Maximal
binding of each mAb was seen to the disulphated LDN structure (6
S)(4S)GalNAc(b1–4)GlcNAc.WhilstmAb9.1.3 showeda strongpref-
erence for this glycan, 5-S19 also bound the related structures Ne
u5Ac(a2–3)GalNAc(b1–4)GlcNAc (as did4-M7)andmonosulphated
(3S)- and (6S)-GalNAc(b1–4)GlcNAc, indicating they target GalNAc
residues with negatively charged substitutions at positions 3, 4
and 6. mAb 5-S19, but neither of the other antibodies, has a weak
affinity for unsubstituted LDN. It is also important that the terminal
residue is GalNAc, since no bindingwas detected to (6S)(4S)Gal(b1–
4)GlcNAc. Finally, substitution of the core GlcNAc residue in (3S)Gal
NAc(b1–4)GlcNAcat position3,with either (3S) or fucose, prevented
binding. Together, this suggests that anti-Glycan B mAbs bind to
negatively-charged LDNmotifs, with one potential target being sul-
phated glycosaminoglycans (GAG).3.2. Mass spectrometric characterisation of ES glycans
Previously, we showed that both Glycans A and B are predom-
inantly conjugated through O- rather than N-linked glycosylation,
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Fig. 1. Characterisation of anti-Glycan B monoclonal antibody specificity. Binding of three distinct anti-Glycan B monoclonal antibodies (clones 9.1.3, 5-S19 and 4-M7) to the
Consortium of Functional Glycomics mammalian glycan array v5.1 (details available at http://www.functionalglycomics.org/static/consortium/resources/resourcecoreh17.
shtml). RFU, relative fluorescent units. Error bars indicate the standard deviation of the mean of six replicates. Monosaccharide composition and linkages as indicated. Dark
filled square, GlcNAc; light filled square, GalNAc; filled circle, galactose; filled triangle, fucose; filled diamond, sialic acid (NeuAc).
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response of infected mice (Hewitson et al., 2011). In preparing
HES glycoproteins for MS analysis, therefore, we first liberated all
N-linked sugars through sequential treatment with PNGase F and
PNGase A, prior to reductive b-elimination to release O-linked
structures. This procedure also offered the opportunity to charac-
terise N-linked structures through MALDI-TOF-MS. We thereby
identified typical N-glycan structures released both by PNGase F
(Fig. 2A) (often with core a1,6-linked fucose) and, to a very limited
extent, by PNGase A (with additional core a1,3-linked fucose (not
shown)). N-Glycan structures extended with multiple hexose and
N-acetylhexosamine residues were detected, some of which appear
to contain a phosphorylcholine (PC) substitution as previously sug-
gested to be present in HES (Hewitson et al., 2011). Closer inspec-
tion of the MALDI-TOF-MS revealed several sets of peaks with mass
differences of 14 Da, indicating the possible occurrence of methy-
lated glycans. These sets of glycan-ions with a mass difference of
14 Da were confirmed by LC–MS analysis and fragmentation of
selected parent ions (e.g. m/z 691.5 [M+2H]2+ (F1H3N3) and m/z
698.7 [M+2H]2+ (meF1H3N3); F, deoxyhexose/fucose; H, hexose;
N,N-acetylhexosamine; meF, methylated fucose; Fig. 2B, C) reveals
that this mass difference is due to the presence of a 160 Da
monosaccharide in place of the core fucose (146 Da), consistent
with an O-methylated fucose residue, as previously reported in
some other nematode glycans (Khoo et al., 1991; Wohlschlager
et al., 2014).
3.3. Mass spectrometric characterisation of O-glycans present in HES
We then analysed total HES O-glycans released by reductive b-
elimination. Released O-glycans were permethylated followed by
purification using liquid–liquid extraction to permit analysis by
MALDI-TOF-MS and LC–MS/MS, which indicated that HES contains
a relatively complex pattern of at least nine small O-linked glycans
with two to five monosaccharide units (Fig. 3A). Predominant were
an unusual tetrasaccharide consisting of a reduced HexNAc residue
tri-substituted with terminal hexoses at m/z 942.5 [M+Na]+
(supporting LC–MS/MS fragmentation spectrum is shown in Sup-
plementary Fig. S2), and the di-substituted variant at m/z 738.4
[M+Na]+. A similarly abundant peak was observed at m/z 1086.6[M+Na]+, which equates to a composition of F2H2N1, likely
representing the di-fucosylated variant(s) of the glycan species at
m/z 738.4 and 912.5 [M+Na]+.
Next, we analysed by MS the permethylated O-glycans liberated
from HF-treated HES. HF cleaves off a1,3-linked fucose, as well as
other relatively labile moieties such as PC (Haslam et al., 2000).
MALDI-TOF-MS ascertained that HF treatment caused the com-
plete loss of the dominant deoxyhexose-containing peak at m/z
1086.6 (F2H2N1), as well as the minor deoxyhexose-containing gly-
can species observed atm/z 953.5 (F1H1N2), 841.5 (F1H3), and 708.4
(F1H1N1), with the emergence ofm/z 779.5 (H1N2), possibly derived
fromm/z 953.5 (F1H1N2) (Fig. 3B) (all ions observed as [M+Na]+). In
contrast, HF treatment left the dominant peaks ofm/z 942.5 (H3N1)
and 738.4 (H2N1), the latter with increased relative intensity due to
defucosylation of F1-2H2N1. Only a single, minor signal was left of a
glycan species with a deoxyhexose residue (m/z 912.5 (F1H2N1)
after HF treatment. Possibly, this signal remains due to incomplete
removal of both fucoses from the major F2H2N1 glycan. These
observations suggest that most deoxyhexoses in HES O-glycans
are a1,3-linked fucose and not a1,4/6-linked fucose (Haslam
et al., 2000), although it is not clear how sensitive a1,2-linked
fucose, if present, would be to HF.
To investigate whether HF sensitive fucose residues form part
of antigenic motifs in HES we also tested the immunological
reactivity of HES following HF treatment. Binding of anti-Glycan
A mAbs is actually enhanced following HF treatment (Fig. 3C),
suggesting that the target epitope may be one of the HF-
resistant structures described. In contrast, binding of anti-
Glycan B mAb 9.1.3 which targets sulphated LDN (Fig. 1) was
completely ablated (Fig. 3D), consistent with the reported effects
of HF to remove side chains from GAGs such as chondroitin sul-
phate (Olson et al., 1985). In addition, we tested binding of an
antibody to PC, a common modification of nematode sugars
(Houston and Harnett, 2004), using the mAb Bp-1 (Sutanto
et al., 1985), and confirmed that whilst this epitope is present
in HES, it is also completely removed by HF (Fig. 3E). The PC-
containing target of mAb Bp-1 and the sulphate-substituted
LDN Glycan B motif are apparently not present or present in only
undetectable relative amounts amongst the HES O-glycans
detected in our MS analyses.
AB
C
Fig. 2. Profiles of N-linked glycans released by PNGase-F treatment from Heligmosomoides polygyrus excretory–secretory products (HES). (A) MALDI-TOF-MS of N-linked
glycans released from Heligmosomoides polygyrus excretory–secretory products by treatment with PNGase F. Glycans were labelled with anthranilic acid and detected in the
negative ion reflectron mode as [MH]. Structural assignments on the basis of monosaccharide composition and N-glycan biosynthetic rules were supported by LC–MS/MS
fragmentation data. The signals marked with ⁄ indicate a contaminating hexose ladder often seen in glycan preparations from diverse sources (Aoki et al., 2008; Talabnin
et al., 2013). Filled square, GlcNAc; filled circle, mannose; filled triangle, fucose; open square, HexNAc, open circle, hexose; me, methylated monosaccharide; PC,
phosphorylcholine. (B–C) LC–MS/MS fragmentation spectra of the glycans detected at m/z 1379.5 and 1393.5 [MH] ion species in (A). Fragmentation of m/z 691.5 (B) and
m/z 698.7 (C) [M+2H]2+ double charged ion-species is indicative of the presence of a methylated core-linked fucose in (C). ⁄, parent ion.
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AB
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Fig. 3. Profiles of O-glycans released by reductive b-elimination from Heligmosomoides polygyrus excretory–secretory products (HES). MALDI-TOF-MS of permethylated (A)
Heligmosomoides polygyrus excretory–secretory products and (B) hydrogen fluoride-treated Heligmosomoides polygyrus excretory–secretory products O-glycans released by b-
eliminationanddetected inpositive ionreflectronmodeas [M+Na]+. Proposedcompositions (HexNAc, opensquare;hexose, opencircle;deoxyhexose, opentriangle;R, reducedend)
and arrangements are based on LC–MS/MS fragmentation spectra (e.g. Supplementary Fig. S2). Unidentified peaks not matching with glycan compositions are marked with ⁄.
Compositions in boxeswithout proposed structure produced ambiguous LC–MS/MS fragmentation patterns (F, deoxyhexose/fucose; H, hexose;N,N-acetylhexosamine). Arrows in
(B) represent deoxyhexose (fucose)-containing glycansmissing in hydrogen fluoride-treatedHeligmosomoides polygyrus excretory–secretory products. (C–E) ELISA reactivity of (C)
anti-Glycan Amonoclonal antibody clone 3–42 (similar results withmonoclonal antibody 13.1 and 2–13, data not shown), (D) anti-Glycan Bmonoclonal antibody clone 9.1.3, and
(E) anti-phosphorylcholine monoclonal antibody clone Bp-1 to native or hydrogen fluoride-treated Heligmosomoides polygyrus excretory–secretory products.
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permethylated, HES O-glycans
To be able to further characterise the O-glycan target of anti-
Glycan A mAb we next employed a recently described approach
to determining antigenic glycans, in which they are isolated,
labelled, fractionated and printed onto solid-phase arrays for
probing with antibody reagents (van Diepen et al., 2012b, 2015).
O-glycans liberated by b-elimination are unsuitable for this purpose
as their reducing end is converted to a non-reactive alditol, and per-
methylation modifies the native structure to the extent it would
likely prevent antibody binding. In addition, in view of the indica-
tions that methylated glycans are present amongst the HES
N-glycans (Fig. 2A–D), structural investigation of intact unmodified
O-glycans allows the identification of methyl-substitutions that
would be obscured by permethylation. O-glycans were therefore
released from HES through hydrazinolysis, using conditions that
favour O-glycan release, followed by N-acetylation, resulting in free
glycans with an intact reducing end sugar. These were then labelled
at the reducing sugar with AA, fractionated, and analysed by LC–
MS/MS prior to printing on a solid support (van Diepen et al., 2015).
RP fractionation of the labelled hydrazinolysis-released
O-glycan repertoire, followed by LC–MS/MS analysis of each
fraction revealed a complex peak pattern with multiple
glycan structures (Fig. 4A, Table 1). Together, this analysis of
hydrazinolysis-released glycans revealed several key new insights.
First, stoichiometric labelling at the reducing end combined with LC
and fluorescence detection provides a more accurate quantification
of different glycans than can be obtained from MALDI-TOF-MS,
where ion suppression prevents reliable observation of the small
di- and trisaccharide glycans. LC (Fig. 4A) and LC–MS/MS (Fig. 4B–
D) reveal that the most abundant glycan structures released by
hydrazinolysis are disaccharides, including H1N1-AA (fractions 14–
17), N2-AA (fractions 17–19) and F1H1-AA (fractions 23–24).
Secondly, whilst there was good concordance between most
abundant glycan species identified following b-elimination and
hydrazinolysis (i.e. F1H1N1-AA, H2N1-AA, F1H3-AA, F1H2N1-AA,
F1H1N2-AA; Table 1), the latter did not yield the H3N1-AA species
(equivalent to b -eliminationm/z 942.5 [M+Na]+). Instead, fractions
15–16 contained a glycan with the putative structure of meH1H2-
N1-AA, where meH represents a methylated hexose residue, based
on LC–MS/MS fragment differences of 176 Da (hexose + 14)
(Fig. 4B), confirming that similar to HES, N-glycans the O-glycans
contain methylated species. We discount the possibility of this
mass representing a hexuronic acid residue (U) as earlier
analysis of permethylated b-elimination material detected
H3N1-AA but no U1H2N1-AA structures (Fig. 3). Interestingly,
several O-glycan species contain a hexose residue at the reducing
end (Table 1). This is uncommon as O-glycans are normally based
on HexNAc. Specific degradation during hydrazinolysis of Galb1–
3GalNAc core types has been observed, leading to the formation
of a reducing hexose residue in schistosome O-glycan samples
(Van Diepen et al., 2015). However, hexose-based glycans were
observed also in the b-elimination-released O-glycan pool
suggesting that degradation during hydrazinolysis is not their
primary source.
Further inspection revealed a number of other methyl-hexose
containing glycan structures, including meH1N1-AA (fractions
20–21), meH1H1N1-AA (fractions 16–17, 19–21), meH1H1-AA
(fraction 23) and F1meH1-AA (fraction 26). Moreover, a methyl-
fucosylated species meF1H1-AA (fractions 25–26) was deduced
from the LC–MS/MS spectrum of m/z 462.5 [M+H]+, indicating
the presence of the 160-Da methylated fucose monosaccharide
(Fig. 4C). Methylated sugars behaved as expected during RP
fractionation, eluting at higher concentrations of organic solvent
than their non-methylated equivalent, reflecting their increasedhydrophobicity (Fig. 4A). Finally, the loss-of-mass observations of
204 Da (162+14+14+14) and of 188 Da (146+14+14+14), and the
presence of them/z 344 fragment ion (trimethyl hexose + AA label)
in LC–MS/MS spectra of fractions 19, 22 and 26 are suggestive of
the presence of trimethylated hexose and fucose residues,
respectively (Fig. 4D).
We then probed the printed RP-LC fractions with both poly-
clonal and mAb reagents. Polyclonal antibodies were collected
from mice rendered immune by sequential H. polygyrus infection,
drug-induced clearance, and secondary challenge infection
(McCoy et al., 2008; Hewitson et al., 2011), and were highly reac-
tive to HES but not to the complex glycosylated egg antigens
(SEA) from Schistosoma mansoni (data not shown). Both IgG
(Fig. 4E) and IgM (data not shown) antibodies showed preferential
reactivity with fraction 20 comprising putative methylhexose-
containing di- and trisaccharides; no signal was seen with naïve
mouse sera (data not shown). Furthermore, we found some anti-
Glycan A IgM antibodies (mAb 2–13, 2–62, 3–29 and 3–55) bound
to fraction 20 (Fig. 4F and data not shown), whilst a control IgM
mAb did not (anti-DNP; Fig. 4G), indicating that methylated hexose
is the target of anti-Glycan A mAb 2–13, 2–62, 3–29 and 3–55. A
mAb directed against Glycan B (mAb 9.1.3) was unreactive to the
array (data not shown).
Fragmentation analysis of the antibody-reactive fraction 20 by
MS/MS revealed two principal ion species, m/z 591.2 (Fig. 4H) and
m/z 681.6 (Fig. 4I) [M+H]+. Both contain methylated hexoses and
the latter corresponds to them/z 738.6 [M+Na]+ ion of the H2N1 spe-
cies observed in permethylated HF-treated HES which retained
antibody binding (Fig. 3B). The meH1H1N1 O-glycan consequently
represents a strong candidate for the identity of Glycan A.
3.5. Marked heterogeneity in O-glycans on the VAL-2 antigen
To complement our analysis of total HES O-glycans, we also
analysed glycosylation of a single protein component of HES, the
Glycan A-bearing glycoprotein VAL-2, a member of the CAP domain
protein family (Pfam00188). This was affinity purified from HES
using a specific mAb, alongside the related VAL-3 protein that lacks
Glycan A (Fig. 5A; (Hewitson et al., 2011)). PNGase F- and PNGase
A-treated VAL-2 glycopeptides from each protein were subjected
to b-elimination and MALDI-TOF-MS. Despite VAL-2 and VAL-3
each containing a single predicted N-glycosylation site (N340GS
and N143LS, respectively), in neither case did we detect PNGase
F- or A-released N-glycans by MALDI-TOF-MS (data not shown).
Permethylated O-glycans liberated from VAL-2 by b -elimination
were readily detected (Fig. 5B), revealing similarly heterogeneous
O-glycan modifications to those observed in total HES (Fig. 3A),
with m/z 708.5 (F1H1N1) particularly prominent and m/z 942.6
(H3N1) also strongly represented. In all, 10 distinct structures were
determined by LC–MS/MS, including one with m/z 779.6 (H1N2)
that was not observed in total HES. Other differences to total HES
O-glycans included the complete absence from VAL-2 of the m/z
1086.6 (F2H2N1) species, confirming this structure is not Glycan
A, a conclusion already supported by the HF-sensitivity of this gly-
can (Fig. 3B). In contrast to VAL-2, except for signals with a very
low signal-to-noise ratio representing H2N1 (m/z 738.6, [M+Na]+)
and H1N1 (m/z 512.3 [M+H]+), no O-linked glycans were detected
in VAL-3 (data not shown), which is consistent with VAL-3 having
very few serine or threonine residues predicted to be O-
glycosylated (Hewitson et al., 2011).
3.6. Glycan A is not responsible for the immunomodulatory effects of
HES
HES is able to both inhibit in vitro DC activation in response to
inflammatory stimuli (Segura et al., 2007; Massacand et al., 2009)
BAA AA
MeMe
Me
Me
*
LC-MS/MS fragmentation spectrum of parent ion m/z 843.8 [M+H]+ from fraction 15
†
A 14 15 16 17 18 19 20 21 22 23 24 25 26
Fl
uo
re
sc
en
ce
Retention time (min)
AA
AAAA
AA
Me
AA
AA
AA
Me
AA
Me
AA
Me
AA
AA
AA
AA
Me
AA
AA
AA
AA
AA
AA
Me
AA
Me
AA
Me
AA
Me
AA
Me
AA
204
AA
AA
AA
204
AA
AA
AA
Me
AA
AA
Me
AA
Me
AA
Me
AA
MeMe
Me
AA
MeMe
Me
C
AA
Me
*
AA
Me
LC-MS/MS fragmentation spectrum of parent ion m/z 462.5 [M+H]+ from fraction 25
Fig. 4. Antibody reactivity to reverse phase LC-fractions of hydrazinolysis-released O-glycans of Heligmosomoides polygyrus excretory–secretory products (HES). (A) Reverse
phase-chromatogram of anthranilic acid labelled O-glycans released from Heligmosomoides polygyrus excretory–secretory products by hydrazinolysis. Fractions of anthranilic
acid labelled glycans were manually collected following reverse phase-LC separation and individual fractions analysed by LC–MS/MS (B–D, H–I) and MALDI-TOF-MS/MS (data
not shown) for glycan fragmentation signatures (anthranilic acid-labelled HexNAc, hexose or deoxyhexose, or methylated variants thereof). Proposed compositions are shown
(HexNAc, open square; hexose, open circle; deoxyhexose, open triangle; Me, methylated monosaccharide; AA, anthranilic acid. (B) Fragmentation of glycanm/z 843.8 [M+H]+
found in LC-fractions 15 and 16. Loss of mass 176 (hexose 162 + 14 Da) is suggestive of single methylation of hexose in meH1H2N1-anthranilic acid, with core HexNAc (203
+ 140 anthranilic acid label = 343). y Represents loss of water (18 Da). (C) Fragmentation of glycanm/z 462.5 [M+H]+ found in LC-fractions 25 and 26. Loss of mass 160 (fucose
146 + 14 Da) suggests fucose methylation in meF1H1-anthranilic acid with core hexose (162 + 140 anthranilic acid label = 302). (D) Fragmentation of glycanm/z 490.5 [M+H]+
found in LC-fraction 26 is consistent with two distinct glycan structures. Core hexose (162 + 140 anthranilic acid label = 302) bound to potential trimethylated fucose (146 + 14
+ 14 + 14 = 188) and core trimethylated hexose (162 + 140 anthranilic acid label + 14 + 14 + 14) bound to fucose (146). y, loss of water (18 Da). (E–G) Antibody reactivity to
glycan-containing LC-fractions 14–26. (E) Secondary infection IgG, (F) anti-glycan A IgM monoclonal antibody 3–55, (G) anti-DNP IgM isotype control monoclonal antibody.
(H–I) Fragmentation spectra of glycans (H) m/z 591.2 [M+H]+ and (I) m/z 681.6 [M+H]+ found in LC-fraction 20, which reacts with anti-Glycan A monoclonal antibody.
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tion (McSorley et al., 2012). In both instances, these effects have
been reported to be resistant to heat denaturation, suggesting arole for parasite glycans. To investigate whether (heat-stable)
Glycan A was responsible for these effects, we initially determined
whether native or heat-denatured Glycan A-bearing VAL-2 was
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marrow derived DCs (BMDCs). However, in contrast to an earlier
report (Massacand et al., 2009) we found that the inhibitory effect
of HES was completely ablated when HES was heat-treated, and
that native Glycan A-bearing VAL-2 was similarly unable to modu-
late DC activation (data not shown).
We did, however, find that in accordance with our previous
publication (McSorley et al., 2012), heat-treated HES retained
immunosuppressive activity in a murine allergy model. Thus,
treatment of mice with HES during immunization with ovalbumin
in alum adjuvant significantly inhibited eosinophilia in both BAL
(Fig. 6A) and lung tissue (Fig. 6B), and this effect was replicated
with heat-denatured HES. However, an equivalent treatment
regime with purified VAL-2 (native or heat-denatured) failed toreduce eosinophil numbers. Together, this suggests that whilst
parasite glycans may be able to inhibit alum-dependent sensitisa-
tion to allergic stimuli, this is not due to either Glycan A or indeed
any of the other O-glycans linked to VAL-2.
4. Discussion
Glycans play a critically important part in the ability of para-
sites to interact with their chosen host, and in the manner in which
the host immune response to infection unfolds (Nyame et al., 2004;
Hokke et al., 2007; Harn et al., 2009; van Die and Cummings, 2010;
Prasanphanich et al., 2013). The murine intestinal nematode H.
polygyrus is a widely studied model of chronic helminth infection
in which host immunity is profoundly down-modulated by a range
Table 1
Comparison of O-glycans released from Heligmosomoides polygyrus excretory–secretory products by hydrazinolysis and reductive b-elimination. O-glycans were liberated from
Heligmosomoides polygyrus excretory–secretory products by hydrazinolysis as detailed in Section 2.6, labelled with anthranilic acid, and fractionated by reverse-phase liquid
chromatography (RP-LC). Fractions were analysed by LC–MS/MS with glycans detected as [M+H]+. Compositions are based on m/z values and MS/MS fragmentation patterns.
Equivalent permethylated glycans obtained by b-elimination (b-elim.) are also indicated.
LC-fraction LC–MS [M+H]+ Composition b-Elim. generated permethylated
equivalent detected at
Notes
14 505.4 H1N1-AA m/z 512.6 [M+H]+
14 667.2 H2N1-AA m/z 738.5 [M+Na]+
14 708.5 H1N2-AA m/z 779.6 [M+Na]+ Only found in VAL-2
15 505.4 H1N1-AA m/z 512.6 [M+H]+
15 843.8 meH1H2N1-AA m/z 942.5 [M+Na]+ With me-hex (D176)
16 505.4 H1N1-AA m/z 512.6 [M+H]+
16 519.6 meH1N1-AA m/z 512.6 [M+H]+ With me-hex (D176)
16 681.8 meH1H1N1-AA m/z 738.5 [M+Na]+ With me-hex (D176)
16 772.8 F1H3-AA m/z 841.5 [M+Na]+ Hexose at reducing end
16 843.8 meH1H2N1-AA m/z 942.5 [M+Na]+ With me-hex (D176)
17 505.4 H1N1-AA m/z 512.6 [M+H]+
17 546.5 N2-AA
17 681.8 meH1H1N1-AA m/z 738.5 [M+Na]+ With me-hex (D176)
17 772.8 F1H3-AA m/z 841.5 [M+Na]+ Hexose at reducing end
18 546.5 N2-AA
18 610.2 F1H2-AA Hexose at reducing end
19 546.5 N2-AA
19 610.2 F1H2-AA Hexose at reducing end
19 681.8 meH1H1N1-AA m/z 738.5 [M+Na]+ With me-hex (D176)
19 709.6 H1N1-AA + D204 With D204 mass suggesting trimethyl-hex
19 756.6 F2H2-AA Hexose at reducing end
20 519.6 meH1N1-AA m/z 512.6 [M+H]+ With me-hex (D176)
20 681.8 meH1H1N1-AA m/z 738.5 [M+Na]+ With me-hex (D176)
21 519.6 meH1N1-AA m/z 512.6 [M+H]+ WITH me-hex (D176)
21 681.8 meH1H1N1-AA m/z 738.5 [M+Na]+ With me-hex (D176)
21 813.2 F1H2N1-AA m/z 912.5 [M+Na]+
21 854.7 F1H1N2-AA m/z 953.5 [M+Na]+
22 547.2 N1-AA + D204 D204 mass suggesting trimethyl-hex
22 651.1 F1H1N1-AA m/z 708.4 [M+Na]+
23 448.4 F1H1-AA Hexose at reducing end
23 477.8 H1meH1-AA With me-hex at reducing end
24 448.4 F1H1-AA Hexose at reducing end
25 462.5 meF1H1-AA With me-fuc (D176), hexose at reducing end
26 462.5 meF1H1-AA With me-fuc (D176), hexose at reducing end
462.5 F1meH1-AA With me-hex at reducing end
26 490.4 H1-AA + D188 D188 mass suggesting trimethyl-fuc, hexose at reducing end
490.4 F1(D204)-AA m/z 344 suggesting trimethyl-hex at reducing end
VAL-2, venom allergen/Ancylostoma secreted protein-like; me-hex, single methylation of hexose; me-fuc, single methylation of fucose; trimethyl-fuc, trimethyl-fucose;
trimethyl-hex, trimethyl-hexose.
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Reynolds et al., 2012). We now show that the HES molecules
include a wide range of glycan formations including several
methylhexose and methylfucose conjugates that represent novel
structures, and two glycosylated targets recognised by mAbs gen-
erated in infected mice.
The host immune response to H. polygyrus is dominated by
antibodies to glycan specificities in the secreted products, HES
(Hewitson et al., 2011). Whilst class-switched IgG1 antibodies
are essential mediators of immunity to gut nematodes (McCoy
et al., 2008; Liu et al., 2010; Hewitson et al., 2015), the
anti-glycan response (comprising both IgM and class-switched
antibody isotypes) appears non-protective (Hewitson et al.,
2011). Glycan immunogenicity in the absence of overt anti-
parasite effects is consistent with glycan ‘‘gimmickry”, whereby
(potentially antigenic) helminth sugars actively manipulate the
host immune response to prevent immunity (van Die and
Cummings, 2010; Prasanphanich et al., 2013). Because of this, in
characterising the overall glycan repertoire within HES, we also
focussed on two main antigenic sugars in H. polygyrus infection,
Glycans A and B.
The global glycan profile of HES reveals extensive and varied
O-glycosylation, together with relatively restricted forms ofN-glycosylation. Nevertheless, our studies provide evidence for
methylation of both O- and N-linked glycans. One of the major sug-
ars released from HES following b-elimination is a tri-substituted
reducing HexNAc with three linked hexoses (H3N1 following
sample permethylation). However, this is not detected in the
(non-permethylated) hydrazine-released glycan pool, and instead
a HexNAc with two bound hexoses and a 176 Da molecular species
is seen. Whilst this could represent either a methylated hexose or a
hexuronic acid, we view the latter as unlikely since we failed to
detect a permethylated hexuronic acid in the b-elimination mate-
rial. Additionally, the presence of methylated fucoses in the enzy-
matically released N-glycans (as well as in the hydrazinolysis
released O-glycans) provides further evidence for this modification
Glycan methylation has previously been found in bacteria, fungi
and plants (Staudacher, 2012), as well as both parasitic (Khoo
et al., 1991) and free-living (Guérardel et al., 2001; Haslam and
Dell, 2003; Cipollo et al., 2005) nematodes, although multiple
methylation of a single monosaccharide as found in H. polygyrus
has only previously been reported in the deep sea annelid worm
Alvinella pompejana (Talmont and Fournet, 1991).
Our data suggest that Glycan A represents a methylated di- or
trisaccharide where the methyl group is present on a hexose resi-
due. Glycan A is an immunodominant O-linked glycan coupled to
AB
Fig. 5. Profiles of venom allergen/Ancylostoma secreted protein-like (VAL-2) O-glycans released by reductive b-elimination. (A) One-dimensional silver stained SDS–PAGE of
Heligmosomoides polygyrus excretory–secretory products (HES), VAL-2-depleted Heligmosomoides polygyrus excretory–secretory products, native VAL-2, VAL-2 and
3-depleted Heligmosomoides polygyrus excretory–secretory products and native VAL-3. Mw markers (kDa) are indicated. (B) MALDI-TOF-MS of permethylated VAL-2 glycans
released by b-elimination and measured as in Fig. 3. HexNAc, open square; hexose, open circle; deoxyhexose, open triangle; R, reduced end.
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two CAP domains (Pfam00188) bridged by a glycosylated serine/
threonine linker region (Hewitson et al., 2011). The isolation of areactive Glycan A fraction by RP-chromatography required
hydrazinolysis as methods employing permethylation would
destroy the epitopic structure of the antigen, and to allow printing
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Fig. 6. Venom allergen/Ancylostoma secreted protein-like antigen (VAL-2) does not inhibit allergic lung inflammation. Ovalbumin in alum adjuvant (OVA) airway
inflammation was induced as detailed in Section 2.9 with Heligmosomoides polygyrus excretory–secretory products (HES), heat-denatured (hd) Heligmosomoides polygyrus
excretory–secretory products, native VAL-2 or hdVAL-2 delivered during sensitisation. On day 31 after first sensitisation, bronchioalveolar lavage (A) and lung tissue (B)
eosinophil numbers were determined by fluorescence-activated cell sorting. Values represent the mean of four mice per group ± S.E.M. Significance was determined by
ANOVA compared with the ovalbumin in alum adjuvant group, or as indicated. *P < 0.05, **P < 0.01, ***P < 0.001, not significant (n.s.; P > 0.05).
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extends that taken previously with N-linked and O-linked glycans
and glycolipids in schistosome-infected individuals (van Diepen
et al., 2012a, 2015), we were concerned that hydrazinolysis and
subsequent labelling of the reducing sugar might also destroy O-
linked epitopes, which encompass core residues, rather than
antennary structural motifs common for N-linked glycans or larger
O-glycans observed in schistosomes. Nevertheless, anti-Glycan A
mAb bound to a single RP fraction (F20), as did polyclonal antibod-
ies from immune mice. This reactive fraction contains methylated
di- and tri-saccharides. Interestingly, it was previously found
that methylated hexoses are also immunodominant antibody
targets following infection with the nematode Toxocara canis
(Schabussova et al., 2007)
Our work also provides a structural basis for antigenicity of
Glycan B. This second immunogenic epitope is expressed on two
components in HES, a heterodispersed high molecular weight anti-
gen and a 65 kDa molecule, neither of which stained well with
silver, suggestive of low protein content (Hewitson et al., 2011).
Using a mammalian glycan array we now show that anti-Glycan
B antibodies bind strongly to sulphated LDN motifs. Similar
binding was also observed to LDN with a2,3-linked sialic acid, a
monosaccharide generally absent from helminths (Johnston et al.,
2009) and not found in this study. However, LDN-like structures
were not observed following b-elimination or hydrazinolysis. This,
coupled with the high molecular weight diffuse character of the
major Glycan B-bearing antigen, suggests that the target is a
GAG-containing polysaccharide of molecular mass greater than
the detection range of the MS analyses (Yamada et al., 1999;
Toyoda et al., 2000).
Heligmosomoides polygyrus glycans have previously been impli-
cated in the immunosuppressive effects of this parasite, since heat
denatured HES is able to prevent allergic lung inflammation
(McSorley et al., 2012) and TLR-dependent DC activation
(Massacand et al., 2009). Due to the novel nature of Glycan A, we
tested whether it is an immunomodulatory structure by adminis-
tering the naturally glycosylated protein VAL-2 to mice undergoing
allergic airway sensitisation. However, our results showed that
despite its immunodominance, Glycan A is not immunomodula-
tory in this setting, as neither native nor heat-denatured Glycan
A-bearing VAL-2 reduces lung eosinophilia. The immunogenicity
of Glycan A in the absence of overt immunosuppressive ability
would be consistent with it fulfilling a diversionary role in gener-
ating ineffective antibodies. Alternative biochemical separation
and affinity purification approaches are now being taken to
identify the heat-stable immunomodulatory components in HES,
which may or may not be carbohydrate in character.Taken together, our results establish that H. polygyrus secretes a
number of O-linked glycoconjugates, with marked glycan hetero-
geneity evident even on a single glycoprotein. Thus, if Glycan A
is elaborated by the parasite as a decoy, this may have evolved
to permit other glycans to function as modulators with minimal
interference from host antibodies. Functional roles for these many
other glycoconjugates are yet to be explored, although a number of
potential interactions with the host can be envisaged. For example,
glycans from other helminth species can, through their ability to
ligate host lectin receptors such as C-type lectins (CTL) and galec-
tins expressed by innate cells (e.g. DCs and macrophages), direct
the host immune response (Prasanphanich et al., 2013). Thus,
LeX-containing glycoconjugates similar to those produced by
schisosomes can induce regulatory B cells and macrophages
(Velupillai and Harn, 1994; Atochina et al., 2001, 2008; Terrazas
et al., 2001), and delay transplant rejection (Dutta et al., 2010) as
well as the development of insulin resistance (Bhargava et al.,
2012). LeX containing schistosome glycans have also been shown
to have a key role in Th2 induction (Okano et al., 1999), and are
required for mannose receptor-mediated internalisation of the
ribonuclease omega-1, a pre-requisite for its Th2 skewing ability
(Everts et al., 2012). Although these precise structures are not
expressed by H. polygyrus, similar interactions through one or more
of the many host pathogen pattern recognition receptors may
prove to be important in the ability of this parasite to establish
in the mammalian host.
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